Enabling Vaccine Manufacturing and Viral Vector Production using the iCELLis – a single-use, automated, and closed manufacturing platform

In this podcast, we were fortunate to have a group of experts for a panel discussion on vaccine manufacturing and viral vector production. Interviewees:


Hanna P. Lesch, PhD, Research and Development Director at Finvector Vision Therapies


Jose Castillo, PhD, Co-Founder and CTO of Univercells


Mario Philips, Vice President and General Manager, Single-Use Technologies, Pall Life Sciences


Fabien Moncaubeig, Head of Cell Culture Technologies, Pall Life Sciences


Show Notes are available at cellculturedish.com/enabling-viral-vector-production-and-vaccine-manufacturing-using-the-icellis-a-single-use-automated-and-closed-manufacturing-platform/